Yeonkyu Choi

Yeonkyu Choi

Auto-generated profile, based on publicly available information

Yeonkyu Choi

Department of Psychiatry Seoul National University Hospital Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of the Korean Academy of Child and Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
YCYeonkyu Choi
Yeonkyu Choi
DLDong Yun Lee
Dong Yun Lee
Sangha LeeSangha Lee
Sangha Lee
EPEun-Jin Park
Eun-Jin Park
HYHee Jeong Yoo
Hee Jeong Yoo
YSYun Mi Shin
Yun Mi Shin
Yeonkyu Choi, Dong Yun Lee, Sangha Lee, Eun-Jin Park, Hee Jeong Yoo, and Yunmi Shin. J Korean Acad Child Adolesc Psychiatry 2021;32:154-60. https://doi.org/10.5765/jkacap.210015

27 August 2026 in Psycho-Oncology
Verified
Journal Article
Open access
YCYeonkyu Choi
Yeonkyu Choi
JKJang Sub Kim
Jang Sub Kim
HAHyejeong Ahn
Hyejeong Ahn
SHSoowan Han
Soowan Han
MSMin Cheol Seo
Min Cheol Seo
HPHye Yoon Park
Hye Yoon Park
Background: Cancer‐related distress extends beyond anxiety and depression to existential suffering, including loss of meaning, helplessness, uncertainty, and relational strain. Compassion‐based interventions in psycho‐oncology are promising, but existential outcomes such as demoralization and spiritual well‐being have rarely been examined. Compassion With You (COMwithU) is a brief, five‐session compassion‐based intervention that centers on cultivating self‐compassion, supported by the therapist's compassionate presence and by practices of extending compassion toward others. Methods: This single‐arm feasibility study evaluated COMwithU in adult patients with cancer using a pre‐post‐1‐month follow‐up design. The intervention comprised five individual 60‐min sessions delivered in person or via videoconferencing. Primary outcomes were feasibility and acceptability. Secondary outcomes included anxiety, depression, spiritual well‐being, demoralization, self‐compassion, and intolerance of uncertainty. Linear mixed models examined changes across baseline, post‐intervention, and follow‐up. Results: Of 44 participants who started the intervention, 37 attended at least 3 of 5 sessions, yielding a completion rate of 84.1%. Among 34 full completers, 31 (91.2%) completed the post‐intervention assessment, and 30 (88.2%) completed the follow‐up. Helpfulness was rated highly (mean 4.63/5). Anxiety, depression, spiritual well‐being, demoralization, and self‐compassion improved significantly, whereas intolerance of uncertainty did not change significantly. Among participants above the demoralization cutoff at baseline, 68.0% showed reliable improvement, and 56.0% achieved clinically significant change by follow‐up. Conclusions: COMwithU demonstrated good feasibility, high acceptability, and promising preliminary effects in patients with cancer. The strongest effects were observed for demoralization and spiritual well‐being. Further randomized controlled trials should directly assess self‐compassion, relational compassion processes, and existential outcomes. Trial registration: This study was registered at the Clinical Research Information Service (CRIS), Republic of Korea (Registration number: KCT0010315)